Wu Zhong,Song Li,Yanqun Zeng,Junhai Xiao,Xinbo Zhou,Zhibing Zheng,Xingzhou Li,Xiaokui Wang,Lili Wang
申请号：
US15105702
公开号：
US10023565B2
申请日:
2014.12.19
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to a compound of formula (I), a stereomeride, pharmaceutically acceptable salt, a solvate or an N-oxide thereof, a medicine composition comprising the compound, a method for preparing the compound, and a usage of the compound in treating diseases related to Hsp70. The diseases are preferably selected from tumors, neurodegenerative diseases, and allogeneic transplantation rejection and infection.
